Pierre Fabre Launches Pivotal Trial Of Pioneering Prenatal Therapy
XLHED Drug Finally Makes It To The Clinic
Executive Summary
The first boy suffering from X-linked hypohidrotic ectodermal dysplasia has been injected with a protein replacement therapy developed by the French firm and the Esperare Foundation while inside his mother's womb.